MARKET PULSE-Celsion, Kemet, Harte-Hanks, Hhgregg, Halozyme
Jan 31 (Reuters) - Some U.S. stocks on the move on Thursday:
WALL STREET FLAT AFTER MIXED DATA; QUALCOMM LIFTS NASDAQ
U.S. stocks were little changed on Thursday as investors mulled a mixed bag of economic data, though earnings from Qualcomm helped lift the Nasdaq. The Dow Jones industrial average gained 0.16 percent. The Standard & Poor's 500 Index rose 0.01 percent. The Nasdaq Composite Index rose 0.27 percent.
** CELSION CORP, $1.54, down 80 pct (1234 ET)
The company said a late-stage study of its experimental liver cancer treatment ThermoDox did not meet the main goal of increasing patients' survival without their cancer worsening. Continued...